Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer. | Cancer Res Treat;54(2): 315-329, 2022 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer.

Rivera-Concepcion, Joel; Uprety, Dipesh; Adjei, Alex A.

Affiliation

Rivera-Concepcion J; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Uprety D; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.
Adjei AA; Department of Oncology, Mayo Clinic, Rochester, MN, USA.

Cancer Res Treat ; 54(2): 315-329, 2022 Apr.

Article in En | MEDLINE | ID: mdl-35209703

Subject(s)
Key words

Challenges; Cost; Drug resistance; Lung neoplasms; NSCLC; Non-small cell lung cancer; Targeted therapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: Cancer Res Treat Year: 2022 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: Cancer Res Treat Year: 2022 Document type: Article Affiliation country: